On Alcohol Addiction for the Patient With Cancer
In 1997, I went to substance abuse treatment three times, plus I made good on a reservation to the psyche ward.
For decades, a doctor refused to charge patients who couldn’t pay. When he couldn’t pay, his patients came to his aid.
Dr. Michael Zollicoffer, known affectionately by his patients as Dr. Z., is a 66-year-old private family practitioner who is rich not in money — he says he is pretty much broke — but flush with job satisfaction.
How the Cancer Moonshot Is Making a Difference for Patients Here and Across the World
Catharine Young, PhD, has spent the past decade of her career focused on cancer policy and advocacy. A native of Johannesburg, South Africa, Dr. Young served as Senior Director of Science Policy at the Biden Cancer Initiative, which began in 2017 by then former Vice President Joe Biden.
Oncologists Reflect on Pandemic’s Lasting Impact on Cancer Care
In a recent episode of Oncology on the Go, several oncologists discussed the impact of the COVID-19 pandemic on oncology care, 5 years later. Each doctor discussed a different aspect of multidisciplinary care, including medical oncology, radiation oncology, and epidemiology.
Why colorectal cancer is often only caught when it’s in late stages — as rates under 45 are on the rise
Normally, we prefer our bowels to keep it low-key. But experts say that silence is exactly what allows colorectal cancer to fly under the radar and turn deadly.
How States Can Prepare if Medicaid Funding Is Cut
Swift policy shifts have placed Medicaid funding under scrutiny since President Donald J. Trump's return to the White House, raising concerns about potential cuts that would threaten coverage for nearly 80 million Americans enrolled in Medicaid.
Aspirin may prevent cancer from moving to other parts of the body
Scientists have been investigating how certain common medications might hold back the movement of cancer cells.
“We Are Losing Lives”: Cancer Advocacy Group Sounds Alarm Over Policy Changes
The Leukemia & Lymphoma Society (LLS) is raising concerns about recent federal policy changes and executive actions by the Trump administration that they say threaten cancer research and patient care, warning that funding cuts could derail progress.
Op-Ed: Low-income patients deserve far better from controversial drug program
A little-known, controversial federal drug program named the 340B Drug Pricing Program is making national headlines for its impact on raising prescription drug prices on the vulnerable patients it was intended to benefit. New Jersey patients should be on alert, as this massive drug program is used by a number of hospitals in our communities, and consumers could be paying more as a result.
Trial examines whether targeted steam can destroy prostate cancer
Researchers at Keck Medicine of USC are part of a national, multisite clinical trial to evaluate a minimally invasive water vapor system that uses steam to treat prostate cancer.
